The Company discovers, develops, manufactures and sells products in one of its business segment of pharmaceutical products to prevent and treat human diseases.
BATS data provided in real-time. NYSE, NASDAQ and NYSEMKT data delayed 15 minutes.
Real-Time prices provided by BATS. Market data provided by Interactive Data.
Company fundamental data provided by Morningstar. Earnings Estimates, Analyst Ratings and Key Statistics provided by Zacks.
SEC Filings and Insider Transactions provided by Edgar Online.
Powered and implemented by Interactive Data Managed Solutions. Terms & Conditions
RSS Headlines
Fool UK
Recs
Pharaceuticals will suffer under this administration's plan for universal care
I disagree. I think their margins may be squeezed due to lower drug prices. But, I expect their volume may increase offsetting this. I'm not highly confident they will outperform, but I don't think your explanation is a very good one.
In any case, these scumbags sell more harmful drugs to Americans than all the drug lords in Columbia.
A sale (legal or not) takes a willing buyer
Obama out in 2012, if were not all dead